Bio-Rad has expanded its partnerships by providing InteliQ products and Unity QC data management solutions which helps efficiencies in workflow and improve laboratory analytical performance.
Bio-Rad expands joint marketing agreement with Siemens Healthineers, providing quality control products and data management solutions for Siemens Healthineers’ Atellica® platforms.
Bio-Rad has announced that it has been granted authorization to sell or import the Platelia SARS-CoV-2 Total Ab test in Canada.
New features of the D-10 Hemoglobin Testing System better manages patient results, optimizes quality control, and more closely matches customer workflows and needs.
Bio-Rad announces the launch of its in vitro diagnostics VIROTROL SARS-CoV-2 and VIROCLEAR SARS-CoV-2 positive and negative quality controls for use in antibody testing of SARS-CoV-2, the virus associated with COVID-19.
Bio-Rad continues to support the worldwide effort to fight SARS-CoV-2, the virus associated with COVID-19 disease, offering instruments, tests, and a SARS-CoV-2 standard to help labs validate COVID-19 assay results.
Bio-Rad announced that Exact Diagnostics, a company that Bio-Rad acquired in the third quarter of 2019, has launched EDX RP Positive Run Control, an unassayed external quality control intended to monitor the performance
Critical security vulnerabilities are reported in VxWorks real-time operating system. It is used in hardware instrumentation (patient monitors, industrial controllers, robotics, firewalls, routers, modems and printers).
Bio-Rad announced the launch of InteliQ, a range of quality controls offered in a tube configuration that provides efficiencies in both workflow and data management.
Bio-Rad announced the availability of Liquichek Serum Indices that are used as part of laboratory interference testing to monitor an instrument’s ability to detect HIL specimen interferences in patient samples.